SlideShare a Scribd company logo
1 of 74
Inflammatory Bowel Disease Dr. Mohammad Shaikhani CABM,FRCP. Updated:2/2011
Introduction  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Risk factors:  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Less common colitis forms are: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical features: UC ,[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical features: Crohn disease   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical features: Crohn disease   ,[object Object],[object Object],[object Object],[object Object]
Clinical features: Crohn disease   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
Environmental Precipitants ,[object Object],[object Object],[object Object]
 
UC
Distinguishing characteristics of CD and UC UC CD Feature  Only colon (rarely  “ backwash ileitis ” SB or colon Location  Continuous, begins distally Skip lesions Anatomic distribution Involved in >90% Rectal spare Rectal involvement Universal  Only 25% Gross bleeding Rare  75% Peri-anal disease No  Yes  Fistulization  No  50-75% Granulomas
Endoscopic features of CD and UC UC CD Feature  Continuous  Discontinuous  Mucosal involvement Rare  Common  Aphthous ulcers Abnormal  Relatively normal  Surrounding mucosa Rare  Common  Longitudinal ulcer No  In severe cases Cobble stoning Common  Uncommon  Mucosal friability distorted  Normal  Vascular pattern
Pathologic features of CD and UC UC CD Feature  Uncommon  Yes  Transmural inflammation  No  50-75% Granulomas  Rare  Common  Fissures  No Common  Fibrosis  Uncommon  Common  Submucosal inflammation
Radiologic features of CD and UC UC CD Feature  Collar button ulcers Nodularity granularity cobble stoning string sign of SB
Comparison of Features in Ulcerative Colitis and Crohn's Disease Crohn's Disease Ulcerative Colitis Feature Transmural Mucosal Depth of inflammation Skip areas Contiguous Pattern of disease Mouth to anus Colorectum Location Less common Usual Rectal involvement Common Backwash ileitis (15%–20% of patients ) Ileal disease Common Rare Fistulas Common Rare Perianal disease 10%–30%  of patients Unlikely Granulomas Less common Usual Overt bleeding More common Unlikely Malnutrition Colorectal cancer, small bowel cancer (depending on disease location ) Colorectal cancer, cholangiocarcinoma (if primary sclerosing cholangitis is present ) Cancer risk Harmful Protective Tobacco use
UC
CD
 
DDX of UC ,[object Object],[object Object],[object Object]
CD ,[object Object],[object Object],[object Object]
CD ilitis: DDx ,[object Object],[object Object],[object Object]
Extra-intestinal manifestations of IBD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Extra-intestinal manifestations of IBD ,[object Object],[object Object],[object Object],[object Object],[object Object]
Extra-intestinal manifestations of IBD ,[object Object],[object Object],[object Object],[object Object],[object Object]
Extra-intestinal manifestations of IBD ,[object Object],[object Object],[object Object],[object Object]
Extra-intestinal manifestations of IBD ,[object Object],[object Object],[object Object],[object Object]
 
 
 
 
 
Complications of IBD ,[object Object],[object Object],[object Object],[object Object],[object Object]
Complications of IBD
Dignosis/assessing severity & extent: ,[object Object],[object Object],[object Object]
Dignosis/assessing severity & extent: ,[object Object],[object Object],[object Object],[object Object]
Dignosis/assessing severity & extent: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dignosis/assessing severity & extent: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dignosis/assessing severity & extent: ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dignosis/assessing severity & extent: ,[object Object],[object Object],[object Object]
 
 
 
 
 
 
 
 
 
 
Treatment  :outline ,[object Object]
Treatment  : 5-ASA (sulfasalazine,  olsalazine, balsalazide, mesalamine: oral, rectal  UC: induction/maintenance   CD (weak): induction/maintenance  Inters nephritis (rare   Diarrhea (olsalazine) Medication  Indication  Side Effects
Treatment  : Antibiotics: Metronidazole, Ciprofloxacin  CD: perianal/ colonic disease Metronidazole:PN  , metallic taste, antabuse effect   Ciprofloxacin: arthropathy, seizure) Medication  Indication  Side Effects
Treatment  : CS (oral, IV, rectal)  UC/CD: induction, not maintenance Acne, moon facies, truncal obesity, osteoporosis, osteonecrosis, DM, hypertension, cataracts, inf Budesonide  CD (ileal/R colon): induction  Minimal CS effects Medication  Indication  Side Effects
Treatment  : Methotrexate  CD: induction/maintenance Bone marrow suppression, hepatotoxicity, pulmonitis 6-MP, Azathioprine  UC/CD: steroid withdrawal, maintenance Pancreatitis, fever, infection, leukopenia, hepatotoxicity, lymphoma Anti–TNF-α: Infliximab  UC/CD: induction/maintenance Infusion reaction, tuberculosis reactivation, demyelination, infection,HF,Lymphoma. Adalimumab UC/CD: induction/maintenance Cyclosporine  UC: steroid refractory Hypertension, nephro &neurotoxicity Medication  Indication  Side Effects
Treatment  : Crohn Disease ,[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  : Crohn Disease ,[object Object],[object Object],[object Object],[object Object]
Treatment  : Crohn Disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  : Crohn Disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  : Crohn Disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  : Crohn Disease ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  : UC ,[object Object],[object Object],[object Object]
Treatment  : UC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  : UC ,[object Object],[object Object],[object Object]
Treatment  : UC ,[object Object],[object Object],[object Object]
Infliximab - mucosal healing Baseline Week 10 Week 54 Rutgeerts et al.  DDW 2002: [abstract] W1367.
 
Microscopic colitis   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Microscopic colitis   ,[object Object],[object Object],[object Object],[object Object]
 
 

More Related Content

What's hot

What's hot (20)

Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Chronic cholecystitis & Jaundice
Chronic cholecystitis & JaundiceChronic cholecystitis & Jaundice
Chronic cholecystitis & Jaundice
 
INFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASEINFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASE
 
Acute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptxAcute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptx
 
IBD - presentation
IBD - presentationIBD - presentation
IBD - presentation
 
Acute cholecystitis
Acute cholecystitisAcute cholecystitis
Acute cholecystitis
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease
 
ULCERATIVE COLITIS MANAGEMENT
ULCERATIVE COLITIS MANAGEMENTULCERATIVE COLITIS MANAGEMENT
ULCERATIVE COLITIS MANAGEMENT
 
inflammatory bowel disease (Ulcerative colitis , crohn's disease)
 inflammatory bowel disease (Ulcerative colitis , crohn's disease)  inflammatory bowel disease (Ulcerative colitis , crohn's disease)
inflammatory bowel disease (Ulcerative colitis , crohn's disease)
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel disease
 
Functional dyspepsia-Approach
Functional dyspepsia-ApproachFunctional dyspepsia-Approach
Functional dyspepsia-Approach
 
Crohns disease movie
Crohns disease movieCrohns disease movie
Crohns disease movie
 
Crohn disease
Crohn diseaseCrohn disease
Crohn disease
 
Chronic pancreatitis
Chronic pancreatitisChronic pancreatitis
Chronic pancreatitis
 
IBD - irritated?
IBD - irritated?IBD - irritated?
IBD - irritated?
 
Biliary Disease
Biliary DiseaseBiliary Disease
Biliary Disease
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Extraintestinal Manifestations OF IBD Inflammatory Bowel Disease : A complet...
Extraintestinal Manifestations OF IBD Inflammatory Bowel Disease :  A complet...Extraintestinal Manifestations OF IBD Inflammatory Bowel Disease :  A complet...
Extraintestinal Manifestations OF IBD Inflammatory Bowel Disease : A complet...
 

Viewers also liked (6)

GIT 4th IBD 2016.
GIT 4th IBD 2016.GIT 4th IBD 2016.
GIT 4th IBD 2016.
 
inflammatory bowel disease (IBD)
inflammatory bowel disease (IBD)inflammatory bowel disease (IBD)
inflammatory bowel disease (IBD)
 
GIT 4th IBD 2015.
GIT 4th IBD 2015.GIT 4th IBD 2015.
GIT 4th IBD 2015.
 
Inflammatory bowel disease,
Inflammatory bowel disease,Inflammatory bowel disease,
Inflammatory bowel disease,
 
IBD
IBDIBD
IBD
 
Ibd ppt
Ibd ppt Ibd ppt
Ibd ppt
 

Similar to IBD for 5th 2011.

21 ulcerative colitis
21 ulcerative colitis21 ulcerative colitis
21 ulcerative colitis
internalmed
 
12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....
12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....
12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....
mekuriatadesse
 

Similar to IBD for 5th 2011. (20)

Git ibd 2012 pretest.
Git ibd 2012 pretest.Git ibd 2012 pretest.
Git ibd 2012 pretest.
 
Ulcerative colitis explanation, management and therapy
Ulcerative colitis explanation, management and therapyUlcerative colitis explanation, management and therapy
Ulcerative colitis explanation, management and therapy
 
Ulcerative colitis
Ulcerative colitisUlcerative colitis
Ulcerative colitis
 
G I T I B D 2010 Lec
G I T  I B D 2010  LecG I T  I B D 2010  Lec
G I T I B D 2010 Lec
 
21 ulcerative colitis
21 ulcerative colitis21 ulcerative colitis
21 ulcerative colitis
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Inflammatory bowel disease- Lower gi hemorrhage
Inflammatory bowel disease-  Lower gi hemorrhageInflammatory bowel disease-  Lower gi hemorrhage
Inflammatory bowel disease- Lower gi hemorrhage
 
Ulcerative colitis
Ulcerative colitisUlcerative colitis
Ulcerative colitis
 
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
 
Ulcerative colitis
Ulcerative colitisUlcerative colitis
Ulcerative colitis
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Inflammatory bowel disease imaging
Inflammatory bowel disease imagingInflammatory bowel disease imaging
Inflammatory bowel disease imaging
 
Crohn’s disease
Crohn’s diseaseCrohn’s disease
Crohn’s disease
 
Ibd
IbdIbd
Ibd
 
12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....
12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....
12 Pathophysiology of IBDnnnnnnnnnnnnnnnnnnnnnn and Diverticular Disease (1)....
 
Crohn’s disease
Crohn’s diseaseCrohn’s disease
Crohn’s disease
 
IBD part 1.pptx
IBD part 1.pptxIBD part 1.pptx
IBD part 1.pptx
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8
 
Lect 6-inf bowel dis
Lect 6-inf  bowel disLect 6-inf  bowel dis
Lect 6-inf bowel dis
 

More from Shaikhani.

More from Shaikhani. (20)

Git j club fiber in git20
Git j club fiber in git20Git j club fiber in git20
Git j club fiber in git20
 
Med j club mm covid20
Med j  club mm covid20Med j  club mm covid20
Med j club mm covid20
 
GIT J Club IBD- sexual dysfunction20.
GIT J Club IBD- sexual dysfunction20.GIT J Club IBD- sexual dysfunction20.
GIT J Club IBD- sexual dysfunction20.
 
GIT J Club IBD- pregnancy2020
GIT J Club IBD- pregnancy2020GIT J Club IBD- pregnancy2020
GIT J Club IBD- pregnancy2020
 
Med 5th geriatrics20
Med 5th geriatrics20Med 5th geriatrics20
Med 5th geriatrics20
 
GIT 4th abd wall pain
GIT 4th abd wall painGIT 4th abd wall pain
GIT 4th abd wall pain
 
GIT 4th endoscopy indications20
GIT 4th endoscopy indications20GIT 4th endoscopy indications20
GIT 4th endoscopy indications20
 
GIT J Club from UEG Week 2018.
GIT J Club from UEG Week 2018.GIT J Club from UEG Week 2018.
GIT J Club from UEG Week 2018.
 
Med j club dm antithrombosis19
Med j club dm antithrombosis19Med j club dm antithrombosis19
Med j club dm antithrombosis19
 
Git 4th GC18.
Git 4th GC18.Git 4th GC18.
Git 4th GC18.
 
GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.
 
GIT 4th indication for upper GI endoscopy.
GIT 4th indication for upper GI endoscopy.GIT 4th indication for upper GI endoscopy.
GIT 4th indication for upper GI endoscopy.
 
GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17 GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17
 
GiIT 4th CRC 2017.
GiIT 4th CRC 2017.GiIT 4th CRC 2017.
GiIT 4th CRC 2017.
 
Git j club colonoscopy mistakes.
Git j club colonoscopy mistakes.Git j club colonoscopy mistakes.
Git j club colonoscopy mistakes.
 
GIT 4th ibd 2017
GIT 4th ibd 2017GIT 4th ibd 2017
GIT 4th ibd 2017
 
GIT 4th IBS 2017
GIT 4th IBS 2017GIT 4th IBS 2017
GIT 4th IBS 2017
 
Ppi seminar hiwa.
Ppi seminar hiwa.Ppi seminar hiwa.
Ppi seminar hiwa.
 
Ppi symposium araz.
Ppi symposium araz.Ppi symposium araz.
Ppi symposium araz.
 
Ppi symposium muhsin
Ppi symposium muhsinPpi symposium muhsin
Ppi symposium muhsin
 

Recently uploaded

會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
中 央社
 

Recently uploaded (20)

Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
 
The Ball Poem- John Berryman_20240518_001617_0000.pptx
The Ball Poem- John Berryman_20240518_001617_0000.pptxThe Ball Poem- John Berryman_20240518_001617_0000.pptx
The Ball Poem- John Berryman_20240518_001617_0000.pptx
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
Benefits and Challenges of OER by Shweta Babel.pptx
Benefits and Challenges of OER by Shweta Babel.pptxBenefits and Challenges of OER by Shweta Babel.pptx
Benefits and Challenges of OER by Shweta Babel.pptx
 
Championnat de France de Tennis de table/
Championnat de France de Tennis de table/Championnat de France de Tennis de table/
Championnat de France de Tennis de table/
 
“O BEIJO” EM ARTE .
“O BEIJO” EM ARTE                       .“O BEIJO” EM ARTE                       .
“O BEIJO” EM ARTE .
 
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinhĐề tieng anh thpt 2024 danh cho cac ban hoc sinh
Đề tieng anh thpt 2024 danh cho cac ban hoc sinh
 
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjj
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjjStl Algorithms in C++ jjjjjjjjjjjjjjjjjj
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjj
 
Graduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxGraduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptx
 
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading RoomSternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....
 
UChicago CMSC 23320 - The Best Commit Messages of 2024
UChicago CMSC 23320 - The Best Commit Messages of 2024UChicago CMSC 23320 - The Best Commit Messages of 2024
UChicago CMSC 23320 - The Best Commit Messages of 2024
 
IPL Online Quiz by Pragya; Question Set.
IPL Online Quiz by Pragya; Question Set.IPL Online Quiz by Pragya; Question Set.
IPL Online Quiz by Pragya; Question Set.
 
Spring gala 2024 photo slideshow - Celebrating School-Community Partnerships
Spring gala 2024 photo slideshow - Celebrating School-Community PartnershipsSpring gala 2024 photo slideshow - Celebrating School-Community Partnerships
Spring gala 2024 photo slideshow - Celebrating School-Community Partnerships
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
 
Chapter 7 Pharmacosy Traditional System of Medicine & Ayurvedic Preparations ...
Chapter 7 Pharmacosy Traditional System of Medicine & Ayurvedic Preparations ...Chapter 7 Pharmacosy Traditional System of Medicine & Ayurvedic Preparations ...
Chapter 7 Pharmacosy Traditional System of Medicine & Ayurvedic Preparations ...
 
Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio App
 
Book Review of Run For Your Life Powerpoint
Book Review of Run For Your Life PowerpointBook Review of Run For Your Life Powerpoint
Book Review of Run For Your Life Powerpoint
 
Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"
Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"
Mattingly "AI and Prompt Design: LLMs with Text Classification and Open Source"
 

IBD for 5th 2011.

  • 1. Inflammatory Bowel Disease Dr. Mohammad Shaikhani CABM,FRCP. Updated:2/2011
  • 2.
  • 3.
  • 4.  
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.  
  • 11.  
  • 12.
  • 13.  
  • 14. UC
  • 15. Distinguishing characteristics of CD and UC UC CD Feature Only colon (rarely “ backwash ileitis ” SB or colon Location Continuous, begins distally Skip lesions Anatomic distribution Involved in >90% Rectal spare Rectal involvement Universal Only 25% Gross bleeding Rare 75% Peri-anal disease No Yes Fistulization No 50-75% Granulomas
  • 16. Endoscopic features of CD and UC UC CD Feature Continuous Discontinuous Mucosal involvement Rare Common Aphthous ulcers Abnormal Relatively normal Surrounding mucosa Rare Common Longitudinal ulcer No In severe cases Cobble stoning Common Uncommon Mucosal friability distorted Normal Vascular pattern
  • 17. Pathologic features of CD and UC UC CD Feature Uncommon Yes Transmural inflammation No 50-75% Granulomas Rare Common Fissures No Common Fibrosis Uncommon Common Submucosal inflammation
  • 18. Radiologic features of CD and UC UC CD Feature Collar button ulcers Nodularity granularity cobble stoning string sign of SB
  • 19. Comparison of Features in Ulcerative Colitis and Crohn's Disease Crohn's Disease Ulcerative Colitis Feature Transmural Mucosal Depth of inflammation Skip areas Contiguous Pattern of disease Mouth to anus Colorectum Location Less common Usual Rectal involvement Common Backwash ileitis (15%–20% of patients ) Ileal disease Common Rare Fistulas Common Rare Perianal disease 10%–30% of patients Unlikely Granulomas Less common Usual Overt bleeding More common Unlikely Malnutrition Colorectal cancer, small bowel cancer (depending on disease location ) Colorectal cancer, cholangiocarcinoma (if primary sclerosing cholangitis is present ) Cancer risk Harmful Protective Tobacco use
  • 20. UC
  • 21. CD
  • 22.  
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.  
  • 32.  
  • 33.  
  • 34.  
  • 35.  
  • 36.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.  
  • 45.  
  • 46.  
  • 47.  
  • 48.  
  • 49.  
  • 50.  
  • 51.  
  • 52.  
  • 53.  
  • 54.
  • 55. Treatment : 5-ASA (sulfasalazine, olsalazine, balsalazide, mesalamine: oral, rectal UC: induction/maintenance CD (weak): induction/maintenance Inters nephritis (rare Diarrhea (olsalazine) Medication Indication Side Effects
  • 56. Treatment : Antibiotics: Metronidazole, Ciprofloxacin CD: perianal/ colonic disease Metronidazole:PN , metallic taste, antabuse effect Ciprofloxacin: arthropathy, seizure) Medication Indication Side Effects
  • 57. Treatment : CS (oral, IV, rectal) UC/CD: induction, not maintenance Acne, moon facies, truncal obesity, osteoporosis, osteonecrosis, DM, hypertension, cataracts, inf Budesonide CD (ileal/R colon): induction Minimal CS effects Medication Indication Side Effects
  • 58. Treatment : Methotrexate CD: induction/maintenance Bone marrow suppression, hepatotoxicity, pulmonitis 6-MP, Azathioprine UC/CD: steroid withdrawal, maintenance Pancreatitis, fever, infection, leukopenia, hepatotoxicity, lymphoma Anti–TNF-α: Infliximab UC/CD: induction/maintenance Infusion reaction, tuberculosis reactivation, demyelination, infection,HF,Lymphoma. Adalimumab UC/CD: induction/maintenance Cyclosporine UC: steroid refractory Hypertension, nephro &neurotoxicity Medication Indication Side Effects
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69. Infliximab - mucosal healing Baseline Week 10 Week 54 Rutgeerts et al. DDW 2002: [abstract] W1367.
  • 70.  
  • 71.
  • 72.
  • 73.  
  • 74.